Evaluation of Renal Damage After PCNL and ESWL Using Novel RNA Based Biomarkers
NCT ID: NCT05077007
Last Updated: 2022-02-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
75 participants
INTERVENTIONAL
2021-01-01
2022-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Previous Open Renal Surgery on Percutaneous Nephrolithotomy Complications
NCT07097883
Contrast-enhanced Ultrasound and Super-resolution Imaging Predict Renal Function Outcome After Nephrectomy
NCT07294859
Changes Post Percutaneous Nephrolithotomy
NCT06185387
Renal Cell Arrest and Damage Biomarkers in Progression and Outcome of Septic AKI
NCT06064487
Ultrasound Markers of Organ Congestion in Severe Acute Kidney Injury
NCT04095143
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Percutaneous nephrolithotomy
patients suffering of pelvic renal stones underwent Percutaneous nephrolithotomy
Percutaneous nephrolithotomy
Endoscopic stone Extraction from the kidney by making a puncture and dilate a tract direct into the kidney through muscle wall and renal parenchyma
Extracorporeal Shock Wave Lithotripsy
patients suffering of pelvic renal stones underwent Extracorporeal Shock Wave Lithotripsy
Extracorporeal Shock Wave Lithotripsy
Using Shock waves from outside the body targeted at a kidney stone causing the stone to fragment. The stones are broken into tiny pieces.
control group
Healthy volunteers with negative history of renal stones or renal impairment to measure the level of urinary markers in their urine samples
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Percutaneous nephrolithotomy
Endoscopic stone Extraction from the kidney by making a puncture and dilate a tract direct into the kidney through muscle wall and renal parenchyma
Extracorporeal Shock Wave Lithotripsy
Using Shock waves from outside the body targeted at a kidney stone causing the stone to fragment. The stones are broken into tiny pieces.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Radiopaque stone
3. Able and willing to give informed consent
1. No history of kidney or stone disease
2. Asymptomatic
3. No indwelling ureteral stent
4. Willing to provide medical history information
5. Able and willing to give informed consent
Exclusion Criteria
2. Bleeding disorder
3. Chronic renal failure (eGFR\<30)
4. Ureteral stone
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Science,Technology & Innovation Funding Authority
UNKNOWN
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
waleed Mousa
Role: PRINCIPAL_INVESTIGATOR
Urology Department, Ain Shams University, Abassia, Cairo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Urology Department, Faculty of Medicine, Ain Shams University
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FMASU R 77/ 2021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.